The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Characteristic and management of lung cancer as a secondary malignancy.
Adam Pluzanski
No relevant relationships to disclose
Pawel Badurak
No relevant relationships to disclose
Dariusz M Kowalski
No relevant relationships to disclose
Maciej Glogowski
No relevant relationships to disclose
Katarzyna Zajda
No relevant relationships to disclose
Maciej Jerzy Krzakowski
No relevant relationships to disclose